Skip to main navigation Skip to search Skip to main content

Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish (US)
Pages (from-to)1140-1143
Number of pages4
JournalLeukemia
Volume26
Issue number5
DOIs
StatePublished - May 2012

Funding

We thank Chris Koontz, Sarah Bowden and Suzanne Wickens for administrative support. This study was supported by NHLBI grant HL082978-01 (MWD) and the Leukemia and Lymphoma Society (MWD). ET is supported by T32 Molecular Hematology Training Grant HL007781-18. This study was supported by the Hannelore-Munke Fellowship and grant #109686 by the Deutsche Krebshilfe awarded to FD; HiLF grant from Hannover Medical School awarded to FT; association ‘Laurette Fugain’ (OAB and FD); grant ‘Direction de la recherche clinique AP-HP (PHRC MDS-04)’ and INCa translational research 2008 awarded to FM; grant No. DJCLS R 10/22 from the Deutsche-José-Carreras Leukämie-Stiftung e.V.; grant No. 109003 from the Deutsche Krebshilfe e.V; and grant No. M 47.1 from the H. W. & J. Hector Stiftung. We thank the investigators of the German myelodysplastic study group and the Groupe Francophone des Myélodysplasies (Dr B Slama, Avignon; Dr Gardembas, Angers; Dr Dib, Angers; Dr Rose, Lille; Dr Cheze, Caen; Dr Ame, Strasbourg; Dr Gyan, Tours) for including patients, and Martin Wichmann, Kerstin Göhrlich, Lamya Slama, Gaelle Herledan and Julien Brard for technical assistance.

FundersFunder number
Direction de la Recherche CliniquePHRC MDS-04
H. W. & J. Hector Stiftung
Hannelore-Munke Fellowship109686
MWDHL007781-18
National Institute of Health National Heart, Lung, and Blood InstituteHL082978-01
Leukemia and Lymphoma Society
Medizinischen Hochschule Hannover
José Carreras Leukämie-Stiftung109003
Deutsche Krebshilfe
Institut National du CancerR 10/22

    ASJC Scopus subject areas

    • Hematology
    • Oncology
    • Cancer Research

    Cite this